Sector
PharmaceuticalsOpen
₹38Prev. Close
₹36.2Turnover(Lac.)
₹1.74Day's High
₹38Day's Low
₹3852 Week's High
₹052 Week's Low
₹0Book Value
₹382.46Face Value
₹10Mkt Cap (₹ Cr.)
78.05P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Jun-2014 | Jun-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Equity Capital | 20.57 | 20.57 | 20.57 | 20.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 765.03 | 757.26 | 671.19 | 590.55 |
Net Worth | 785.6 | 777.83 | 691.76 | 611.12 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Jun-2014 | Jun-2013 | Mar-2012 |
|---|---|---|---|
Revenue | 483.47 | 1,233.09 | 984.68 |
yoy growth (%) | -60.79 | 25.22 | |
Raw materials | -308.35 | -573.09 | -471.35 |
As % of sales | 63.77 | 46.47 | 47.86 |
Employee costs | -112.38 | -151.43 | -108.97 |
| Y/e 31 Mar( In .Cr) | Jun-2014 | Jun-2013 | Mar-2012 |
|---|---|---|---|
Profit before tax | -362.19 | 120.79 | 109.8 |
Depreciation | -29.15 | -36.52 | -27.63 |
Tax paid | -9.93 | -21.96 | -19.43 |
Working capital | -239.12 | -156.42 | |
Other operating items |
| Y/e 31 Mar | Jun-2014 | Jun-2013 | Mar-2012 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -60.79 | 25.22 | |
Op profit growth | -132.74 | 33.09 | |
EBIT growth | -139.46 | 30.14 | |
Net profit growth | -91.54 | 11.49 |
| Particulars (Rupees in Crores.) | Jun-2014 | Jun-2013 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|---|
Gross Sales | 1,006.13 | 1,638.53 | 1,454.28 | 1,332.32 | 964.28 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,006.13 | 1,638.53 | 1,454.28 | 1,332.32 | 964.28 |
Other Operating Income | 2.76 | 3.17 | 2.34 | 2.45 | 1 |
Other Income | 396.92 | 32.7 | 30.59 | 28.04 | 8.65 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
Alok Jagdish Saxena
Director
Edoardo Carlo Richter
Company Secretary
Vijendra Jain
Additional Director
Ravani Mohammed Abdul Khader
Additional Director
Kader Mohammed Davawala
Elder House Plot No C-9,
Dalia Indl Estate Andheri (W),
Maharashtra - 400053
Tel: 91-22-26730058
Website: http://www.elderindia.com
Email: eldercorporate@elderindia.com
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Elder Pharmaceuticals Ltd is one of the fastest growing pharmaceutical companies in India. The companys principal activities include the manufacturing and marketing of prescription pharmaceutical bran...
Read More
Reports by Elder Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.